NOVAREX Co.,Ltd. (KOSDAQ:194700)
South Korea · Delayed Price · Currency is KRW 12,640
+1,040 (8.97%)
At close: Jun 29, 2026
NOVAREX Market Cap
NOVAREX has a market cap or net worth of 217.44 billion as of June 30, 2026. Its market cap has decreased by -30.57% in one year.
Market Cap
217.44B
Enterprise Value
205.19B
Revenue
404.26B
Ranking
n/a
PE Ratio
6.32
Stock Price
12,640.00
Market Cap Chart
Since November 14, 2018, NOVAREX's market cap has increased from 180.98B to 217.44B, an increase of 20.15%. That is a compound annual growth rate of 2.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 217.44B | -12.26% |
| Dec 30, 2025 | 247.83B | 86.67% |
| Dec 30, 2024 | 132.77B | -38.22% |
| Dec 28, 2023 | 214.90B | 19.61% |
| Dec 29, 2022 | 179.68B | -41.23% |
| Dec 30, 2021 | 305.72B | -1.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samyang Biopharm | 317.14B |
| HEM Pharma | 299.61B |
| ImmuneOncia Therapeutics | 291.16B |
| CellBion | 192.29B |
| DAE HWA Pharmaceutical | 153.62B |
| Vivozon Pharmaceutical | 149.81B |
| High Tech Pharm | 135.15B |
| GC WellBeing | 130.36B |